Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study

Virulence

Volumn 8, Issue 1, 2017, Pages 101-108

  Grignolo, Sara ^a   Bruzzone, Bianca ^a   Gabbi, Laura ^a   Gerbaldo, Daniela ^a   Gallo, Fabio ^b   Nigro, Nicola ^a   Icardi, Giancarlo ^a,b   Viscoli, Claudio ^a   Di Biagio, Antonio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; combined antiretroviral therapy; female genital tract; HIV 1; human papillomavirus; sexual transmission; viral shedding

Indexed keywords

VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MAJOR CLINICAL STUDY; MENOPAUSE; MONOTHERAPY; REAL TIME POLYMERASE CHAIN REACTION; SEXUAL TRANSMISSION; TREATMENT DURATION; VAGINA SMEAR; VAGINAL HYSTERECTOMY; VAGINITIS; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VAGINA; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; RNA, VIRAL; VAGINA; VIRUS SHEDDING;

EID: 84982276481     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1216293     Document Type: Letter

References (32)

1. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342(13):921-9; http://dx.doi.org/10.1056/NEJM200003303421303
2. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, 3rd, Whitehouse J, Moye J, Jr, Reichelderfer P, Harris DR, Fowler MG, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341(6):385-93; PMID:10432323; http://dx.doi.org/10.1056/NEJM199908053410601
3. Kalichman S, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen:review and implications of empirical findings. Sexually Transm Dis 2008; 35:55-60; http://dx.doi.org/10.1097/OLQ.0b013e318141fe9b
4. Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC. Effect of highly active antiretroviral therapy on cervico-vaginal HIV-1 RNA. AIDS 2000; 14(4):415-21; PMID:10770544; http://dx.doi.org/10.1097/00002030-200003100-00015
5. Tanton C, Weiss HA, Le Goff J, Changalucha J, Rusizoka M, Baisley K, Everett D, Ross DA, Belec L, Hayes RJ, et al. Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One 2011; 6(3):e17480; PMID:21390251; http://dx.doi.org/10.1371/journal.pone.0017480
6. Alcaide ML, Chisembele M, Malupande E, Arheart K, Fischl M, Jones DL. A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women's health. BMJ Open 2015; 5(11):e009036; PMID:26553833; http://dx.doi.org/10.1136/bmjopen-2015-009036
7. Fiore JR, Suligoi B, Saracino A, Di Stefano M, Bugarini R, Lepera A, Favia A, Monno L, Angarano G, Pastore G. Correlates of HIV-1 shedding in cervico-vaginal secretions and effects of antiretroviral therapies. AIDS 2003; 17(15):2169-76; PMID:14523273; http://dx.doi.org/10.1097/00002030-200310170-00004
8. Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 2010; 24(16):2489-97; PMID:20736815; http://dx.doi.org/10.1097/QAD.0b013e32833e5043
9. Homans J, Christensen S, Stiller T, Wang CH, Mack W, Anastos K, Minkoff H, Young M, Greenblatt R, Cohen M, et al. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervico-vaginal HIV shedding. J Acquir Immune Defic Syndr 2012; 60(1):99-110; PMID:22517416; http://dx.doi.org/10.1097/QAI.0b013e31824aeaaa
10. Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, et al. Cervico-vaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso:a longitudinal study. J Acquir Immune Defic Syndr 2014; 65(2):237-45; PMID:24226060; http://dx.doi.org/10.1097/QAI.0000000000000049
11. Sheth AN, Evans-Strickfaden T, Haaland R, Martin A, Gatcliffe C, Adesoye A, Omondi MW, Lupo LD, Danavall D, Easley K, et al. HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle. J Infect Dis 2014; 210(5):736-44; PMID:24643223; http://dx.doi.org/10.1093/infdis/jiu166
12. Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003; 17(4):455-80; PMID:12598766; http://dx.doi.org/10.1097/00002030-200303070-00001
13. Else LJ, Taylor S, Back DJ, Khoo SH. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites:the male and female genital tract. Antivir Ther 2011; 16(8):1149-67; PMID:22155899; http://dx.doi.org/10.3851/IMP1919
14. Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo J, Kreiss JK. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183(7):1017-22; PMID:11237825; http://dx.doi.org/10.1086/319287
15. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Jr, Ndinya-Achola J, Bwayo JJ, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350(9082):922-7; PMID:9314871; http://dx.doi.org/10.1016/S0140-6736(97)04240-2
16. Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, Plummer F, Ndinya-Achola J, Roberts PL, Hillier S, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993; 269(22):2860-4; PMID:8497089; http://dx.doi.org/10.1001/jama.1993.03500220046024
17. Bunupuradah T, Bowonwattanuwong C, Jirajariyavej S, Munsakul W, Klinbuayaem V, Sophonphan J, Mahanontharit A, Hirschel B, Ruxrungtham K, Ananworanich J,; HIV STAR Study team. HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir. Antivir Ther 2014; 19(6):579-86; PMID:24464590; http://dx.doi.org/10.3851/IMP2737
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, et al. The 2001 Bethesda System:terminology for reporting results of cervical cytology. JAMA 2002; 287(16):2114-9; PMID:11966386; http://dx.doi.org/10.1001/jama.287.16.2114
19. R Core Team (2013). R:A language and environment for statistical computing. R Foundation for Statistical Computing:Vienna, Austria. Available at http://www.R-project.org (Accessed on:November12, 2015).
20. Moreira C, Venkatesh KK, DeLong A, Liu T, Kurpewski J, Ingersoll J, Caliendo AM, Cu-Uvin S. Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy:a pilot study. Clin Infect Dis 2009; 49(6):991-2; PMID:19694541; http://dx.doi.org/10.1086/605540
21. Uvin SC, Caliendo AM. Cervico-vaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol 1997; 90(5):739-43; PMID:9351756; http://dx.doi.org/10.1016/S0029-7844(97)00411-0
22. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T, Bush TJ, Schnell C, Conley LJ, Clancy KA, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999; 179(4):871-82; PMID:10068582; http://dx.doi.org/10.1086/314656
23. Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, Weber K, Cohen M, Levine A, Minkoff H, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001; 358(9293):1593-601; PMID:11716886; http://dx.doi.org/10.1016/S0140-6736(01)06653-3
24. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, et al. Partners in Prevention HSV/HIV Transmission Study Team. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011; 3(77):77ra29; PMID:21471433; http://dx.doi.org/10.1126/scitranslmed.3001888
25. Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC. Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008; 47(5):553-558.
26. Buve A, Jespers V, Crucitti T, Fichorova RN. The vaginal microbiota and susceptibility to HIV. AIDS 2014; 28(16):2333-44; PMID:25389548; http://dx.doi.org/10.1097/QAD.0000000000000432
27. Venkatesh KK, DeLong AK, Kantor R, Chapman S, Ingersoll J, Kurpewski J, De Pasquale MP, D'Aquila R, Caliendo AM, Cu-Uvin S. Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load. J Womens Health (Larchmt) 2013; 22(4):330-8; PMID:23531097
28. Graham SM, Masese L, Gitau R, Jalalian-Lechak Z, Richardson BA, Peshu N, Mandaliya K, Kiarie JN, Jaoko W, Ndinya-Achola J, et al. Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment. J Infect Dis 2010; 202(10):1538-42; PMID:20923373; http://dx.doi.org/10.1086/656790
29. De Pasquale MP, Leigh Brown AJ, Uvin SC, Allega-Ingersoll J, Caliendo AM, Sutton L, Donahue S, D'Aquila RT. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 34(1):37-44; PMID:14501791; http://dx.doi.org/10.1097/00126334-200309010-00005
30. Pearshouse R. Switzerland:statement on sexual transmission of HIV by people on ART. HIV AIDS Policy Law Rev 2008; 13(1):37-8; PMID:18727190
31. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365(6):493-505; PMID:21767103; http://dx.doi.org/10.1056/NEJMoa1105243
32. Rodger A, Bruun T, Cambiano V, Vernazza P, Estrada V, Lunzen JV, et al. HIV Transmission Risk Through Condomless Sex If HIV+ Partner On Suppressive ART:PARTNER Study. [Abstract] 153LB at CROI 2015.